Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Strnad

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Molecular Pathology : MP|July 31, 2002
Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell linesJ Mad'arová, M Lukesová, A Hlobilková, et al.
Neoplasma|July 5, 2002
Nuclear receptors in early hormone refractory prostate cancer and their relationship to apoptosis-related proteinsZ Kolár, P G Murray, J Madarova, et al.
Cellular and Molecular Life Sciences : CMLS|July 9, 2005
Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitorV Krystof, I W McNae, M D Walkinshaw, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 16, 2011
Frequency of BCR-ABL fusion transcripts in Serbian patients with chronic myeloid leukemiaB Todoric-Zivanovic, M Strnad, D Stamatovic, et al.
Plant Physiology and Biochemistry : PPB|April 2, 2014
Effect of light on growth and endogenous hormones in Chlorella minutissima (Trebouxiophyceae)W A Stirk, P Bálint, D Tarkowská, et al.
Journal of Chemical Theory and Computation|June 29, 2019
Combined Small-Angle X-ray and Neutron Scattering Restraints in Molecular Dynamics SimulationsPo-Chia Chen, Roman Shevchuk, Felix M Strnad, et al.
Investigational New Drugs|January 19, 2000
A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancerR S Witte, S Lipsitz, T L Goodman, et al.
European Journal of Biochemistry|September 1, 1994
Inhibition of cyclin-dependent kinases by purine analoguesJ Veselý, L Havlicek, M Strnad, et al.
Organic & Biomolecular Chemistry|October 8, 2016
Design, synthesis and biological activities of new brassinosteroid analogues with a phenyl group in the side chainM Kvasnica, J Oklestkova, V Bazgier, et al.
Physiological Research|March 1, 2021
In vitro and in silico studies of interaction of synthetic 2,6,9-trisubstituted purine kinase inhibitors BPA-302, BP-21 and BP-117 with liver drug-metabolizing cytochromes P450A Špičáková, P Kraus, T Gucký, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Molecular Pathology : MP|July 31, 2002
Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell linesJ Mad'arová, M Lukesová, A Hlobilková, et al.
Neoplasma|July 5, 2002
Nuclear receptors in early hormone refractory prostate cancer and their relationship to apoptosis-related proteinsZ Kolár, P G Murray, J Madarova, et al.
Cellular and Molecular Life Sciences : CMLS|July 9, 2005
Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitorV Krystof, I W McNae, M D Walkinshaw, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 16, 2011
Frequency of BCR-ABL fusion transcripts in Serbian patients with chronic myeloid leukemiaB Todoric-Zivanovic, M Strnad, D Stamatovic, et al.
Plant Physiology and Biochemistry : PPB|April 2, 2014
Effect of light on growth and endogenous hormones in Chlorella minutissima (Trebouxiophyceae)W A Stirk, P Bálint, D Tarkowská, et al.
Journal of Chemical Theory and Computation|June 29, 2019
Combined Small-Angle X-ray and Neutron Scattering Restraints in Molecular Dynamics SimulationsPo-Chia Chen, Roman Shevchuk, Felix M Strnad, et al.
Investigational New Drugs|January 19, 2000
A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancerR S Witte, S Lipsitz, T L Goodman, et al.
European Journal of Biochemistry|September 1, 1994
Inhibition of cyclin-dependent kinases by purine analoguesJ Veselý, L Havlicek, M Strnad, et al.
Organic & Biomolecular Chemistry|October 8, 2016
Design, synthesis and biological activities of new brassinosteroid analogues with a phenyl group in the side chainM Kvasnica, J Oklestkova, V Bazgier, et al.
Physiological Research|March 1, 2021
In vitro and in silico studies of interaction of synthetic 2,6,9-trisubstituted purine kinase inhibitors BPA-302, BP-21 and BP-117 with liver drug-metabolizing cytochromes P450A Špičáková, P Kraus, T Gucký, et al.
Pageof 9